Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
Abstract Recent clinical development of KRAS inhibitors has heightened interest in the genomic landscape of KRAS-altered cancers. We performed a pan-cancer analysis of KRAS-altered samples from 426,706 adult patients with solid or hematologic malignancies using comprehensive genomic profiling; addit...
প্রধান লেখক: | , , , , , , , , , , , , , , , , , |
---|---|
বিন্যাস: | প্রবন্ধ |
ভাষা: | English |
প্রকাশিত: |
Nature Portfolio
2022-12-01
|
মালা: | npj Precision Oncology |
অনলাইন ব্যবহার করুন: | https://doi.org/10.1038/s41698-022-00334-z |